GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coral Laboratories Ltd (BOM:524506) » Definitions » Capital Expenditure

Coral Laboratories (BOM:524506) Capital Expenditure : ₹0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Coral Laboratories Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Coral Laboratories's cash flow for capital expenditures for the three months ended in Dec. 2024 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.00 Mil.

Coral Laboratories Capital Expenditure Historical Data

The historical data trend for Coral Laboratories's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coral Laboratories Capital Expenditure Chart

Coral Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.80 -13.60 -55.48 -19.45 -9.91

Coral Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Coral Laboratories Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coral Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coral Laboratories Ltd (BOM:524506) » Definitions » Capital Expenditure
Comparable Companies
NSE:BALAXI BOM:531569 BOM:524572 BOM:500009 BOM:531739 BOM:532878 BOM:524654 BOM:530313 BOM:531173 BOM:531726 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Lal Bahadur Shastri Road, No. 3-B, Patanwala Industrial Estate, Opposite Shreyas Cinema, Ghatkopar (West), Mumbai, MH, IND, 400086
Website
https://www.corallab.com
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.

Coral Laboratories Headlines

No Headlines